Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Simcere Pharmaceutical
AddedFeb 16, 2024
UpdatedJun 28, 2026
Simcere Pharmaceutical

Simcere Pharmaceutical

Public

Simcere Pharmaceutical Co., Ltd., a Chinese firm, manufactures human and veterinary pharmaceuticals since 1993.

HQ
Nanjing, Jiangsu, CN
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Simcere Pharmaceutical Co., Ltd., founded in 1993, is a Chinese company dedicated to manufacturing pharmaceuticals for human and veterinary use. The company's core mission is to provide patients with more effective medications, focusing on innovative treatments in areas such as oncology, neurology, autoimmune diseases, cardiovascular, and anti-infection. Simcere aims to advance healthcare by developing and commercializing cutting-edge drugs that address unmet medical needs.

Notable figures associated with Simcere include its leadership team and key investors who have supported the company's growth and innovation. The company has achieved significant milestones, such as the inclusion of its insomnia drug in the 2023 edition of China's Adult Insomnia Diagnosis and Treatment Guidelines and presenting clinical research at major conferences like ASCO. Simcere's impact is evident in its contribution to improving patient outcomes through its innovative pharmaceutical solutions.

Simcere Pharmaceutical - Similar Companies

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

Sino Biopharmaceutical logo

Sino Biopharmaceutical

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

China PharmaHub logo

China PharmaHub

Cerimon Pharmaceuticals logo

Cerimon Pharmaceuticals

cerimon.com

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Haisco logo

Haisco

Zocere logo

Zocere

zocere.com

Qilu Pharmaceutical Co. logo

Qilu Pharmaceutical Co.

Shanghai Junshi Biosciences Co logo

Shanghai Junshi Biosciences Co

junshipharma.com

Ferring logo

Ferring

ferring.com

Sanofi logo

Sanofi

sanofi.com

Zhejiang Xianju Pharmaceutical Co. logo

Zhejiang Xianju Pharmaceutical Co.

Shenzhen Salubris Pharmaceuticals Co. logo

Shenzhen Salubris Pharmaceuticals Co.

Simcere Pharmaceutical - Quick Facts

Who are Simcere Pharmaceutical's competitors?

Companies similar to Simcere Pharmaceutical include Betta Pharmaceuticals Co., Sino Biopharmaceutical, Bayer Pharmaceuticals and Collegium Pharmaceutical.

When was Simcere Pharmaceutical founded?

Simcere Pharmaceutical was founded in 1995.

Where is Simcere Pharmaceutical's headquarters located?

Simcere Pharmaceutical's headquarters is located in Nanjing, Jiangsu, CN.

When was Simcere Pharmaceutical's last funding round?

Simcere Pharmaceutical's most recent funding round was for $600M (USD) in June 2021.

How much has Simcere Pharmaceutical raised to-date?

As of Jun 4, 2021, Simcere Pharmaceutical has raised a total of $600M (USD).

How many employees does Simcere Pharmaceutical have?

Simcere Pharmaceutical has 7,832 employees as of Feb 6, 2024.

Simcere Pharmaceutical - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Asia
  • China
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Distribution
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research